C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
Author:
Affiliation:
1. Department of Oncology Beijing Chao‐Yang Hospital Affiliated with Capital Medical University Beijing China
2. Department of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12908
Reference71 articles.
1. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
2. Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
3. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen
4. Retracted: Quercetin induces endoplasmic reticulum stress to enhance c DDP cytotoxicity in ovarian cancer: involvement of STAT 3 signaling
5. Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen)
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diallyl trisulfide (DATS) protects cardiac cells against advanced glycation end-product-induced apoptosis by enhancing FoxO3A-dependent upregulation of miRNA-210;The Journal of Nutritional Biochemistry;2024-03
2. Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer;2024-01-12
3. Schisandrin C Protects YD-38 Cells from Cisplatin-induced Cell Death by Inhibiting Cytochrome c Release from Mitochondria;Natural Product Sciences;2023-12-31
4. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling;Cell Death & Disease;2023-12-14
5. Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16;Oncogenesis;2023-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3